BioSpace News Archive

Stericycle Communication Solutions, an industry leader in patient engagement technology and solutions and a Strategic Alliance Partner of Yext, Inc. (NYSE: YEXT), the Search Experience Cloud Company, today announced the integration of its InQuicker™ online scheduling solution directly into the Yext platform

PharmaJet, the maker of innovative, needle-free injection technology, announced that the results of the Invectys Phase I clinical trial of its therapeutic cancer vaccine, INVAC-1, using the PharmaJet needle-free injection system, were recently published.

RxGen, a translational research company ensuring definitive, actionable preclinical outcomes through the use of predictive, validated disease models, today announced it is rebranding as Virscio (vir’sio) to reflect substantial expansion of capabilities since inception and growth into a leading nonhuman primate preclinical research organization.

Symmetry Surgical, Inc. (“Symmetry”), is pleased to announce that it has completed its acquisition of The O.R. Company.

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced the Department of Defense (DoD) has awarded APT a contract of $10.2 million for the development of PhageBankTM a personalized bacteriophage therapeutic for the treatment of bacterial infections.

Often known as “forgotten patients,” many childhood cancer survivors face long-term side effects and medical complications post-treatment.

Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their fourth annual Quantitative Systems Pharmacology (QSP) Summit will occur May 20-21, 2020 at the MIT Samberg Conference Center in Cambridge, MA.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the“Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced plans to commence development of a pharmaceutical grade version of Tauri-Gum™

Kaiser Permanente and Service Employees International Union-United Healthcare Workers West (SEIU-UHW) have partnered to establish Futuro Health, a new $130 million nonprofit organization dedicated to growing the largest network of certified health care workers starting in California and spreading throughout the nation